COVID-19: Guidance

Since the start of the pandemic, guidance issued by the regulatory authorities on the management of clinical trials during COVID-19 has been circulated by Cancer Trials Ireland to members following their release.

The regulatory authorities acknowledge the impact the pandemic has on the management of trials. They provide practical guidance both for sponsors and for investigators facing challenges in the management of trials while emphasizing that patient safety should always take precedence in decision making.

The staff at Cancer Trials Ireland is closely monitoring for updates and will continue to inform the members of relevant updates. You will find the latest versions of the guidance at the links below.

European guidance (v3/ 28-Apr-2020)

HPRA guidance (v6/ 28-May-2020)

European guidance (v3/ 28-Apr-2020)